• Return to Headlines

QIAGEN: The Winning Streak Continues (QGEN)

By Nick Russo

QIAGEN (NASDAQ:QGEN) traded today at a new 52-week high of $32.80. Approximately 219,000 shares have changed hands today, as compared to an average 30-day volume of 854,000 shares.

QIAGEN (NASDAQ:QGEN) is currently priced 6.7% above its average consensus analyst price target of $30.54. QIAGEN shares have support at the 200-day moving average (MA) of $24.71 and additional support at the 50-day MA of $22.38.

QIAGEN share prices have moved between a 52-week high of $32.80 and a 52-week low of $19.94 and are now trading 64% above that low price at $32.74 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has slid 0.4%.

QIAGEN N.V. provides technologies for separating and purifying DNA and RNA. The Company's portfolio consists of consumable products for nucleic acid separation, purification, and handling and nucleic acid amplification, as well as automated instrumentation and related services.

SmarTrend recommended that subscribers consider buying shares of QIAGEN on December 9th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $28.54. Since that recommendation, shares of QIAGEN have risen 12.6%. We continue to monitor QGEN for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows qiagen

Ticker(s): QGEN